Non‐invasive prenatal testing for fetal inheritance of maternal β‐thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study
- 6 December 2017
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 125 (4) , 461-468
Abstract
Objective: To evaluate whether targeted sequencing and relative mutation dosage can be used to diagnose correctly inheritance of maternal β‐thalassaemia mutations in cell‐free DNA.Design: Feasibility study using samples collected in a prenatal clinic.Setting: South East Asia.Population: Couples where both partners were known to be carriers of one of four common β‐thalassaemia mutations or an HbE mutation, and therefore at risk of carrying a fetus affected with β‐thalassaemia.Methods: 49 samples previously identified as having inherited a paternal β‐thalassaemia mutation were amplified using nested polymerase chain reaction (PCR), and then sequencing. Relative mutation dosage was used to classify the fetus as having inherited the wild‐type or mutant maternal allele.Main outcome measures: Classification of the fetus as ‘unaffected’ (if the maternal wild‐type allele was inherited) or ‘affected’ with β‐thalassaemia (if the maternal mutant allele was inherited).Results: A classification for inheritance of maternal allele was obtained in 48/49 samples (98.0%). A concordant call was made in 44/48 cases (91.7%): one false‐positive and three false‐negatives were obtained. Thus, we had an overall sensitivity of 87.5% [95% confidence interval (CI) 67.6–97.3%] and a specificity of 95.8% (95% CI 78.9–99.9%) for inheritance of maternal genotype.Conclusions: RMD for detection of inheritance of maternal β‐thalassaemia mutations has potential for clinical use. Our sequential approach could be applied to other single‐gene disorders.Tweetable NIPT for β‐thalassaemia achieved using nested‐PCR followed by relative mutation dosage.Keywords
Funding Information
- National Medical Research Council (NMRC/CSA/0059/2014)
- Natural Science Foundation of Guangdong Province (1414050001657)
This publication has 35 references indexed in Scilit:
- Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysisAnnals of Hematology, 2016
- Non‐invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysisPrenatal Diagnosis, 2015
- Non‐invasive prenatal diagnostic testing for β‐thalassaemia using cell‐free fetal DNA and next generation sequencingPrenatal Diagnosis, 2014
- Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2014
- Client Views and Attitudes to Non‐Invasive Prenatal Diagnosis for Sickle Cell Disease, Thalassaemia and Cystic FibrosisJournal of Genetic Counseling, 2014
- Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasmaPrenatal Diagnosis, 2013
- Non‐invasive prenatal diagnosis of beta‐thalassemia and sickle‐cell disease using pyrophosphorolysis‐activated polymerization and melting curve analysisPrenatal Diagnosis, 2012
- Incidence of haemoglobinopathies in various populations — The impact of immigrationClinical Biochemistry, 2009
- Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-β-thalassemiaTranslational Research, 2007
- Detection of Paternally Inherited Fetal Point Mutations for β-Thalassemia Using Size-Fractionated Cell-Free DNA in Maternal PlasmaJAMA, 2005